Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.
Harness Data
Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.
Discover InnovationsNavigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.
Explore MedTech
Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.
Access InsightsUnlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.
Unlock Innovations
Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.
Navigate Health PlansLeverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.
Streamline Decisions
Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.
Evaluate Risk
Transform into a data-driven organization that enhances your specialty and showcases value to your members through digital transformation.
Enhance Your SpecialtyA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSAs companies realize the potential of Artificial Intelligence (AI) and Machine Learning (ML), applications in healthcare are expected to grow to nearly $8 billion by 2022. The biopharmaceutical industry is increasingly recognizing AI/ML’s potential to both improve decision making across R&D and commercialization, and to drive better outcomes for patients, physicians, and payers.
However, observers have yet to see meaningful and sustained realization of value from AI/ML in the biopharma industry. Further, most internal biopharma AI/ML initiatives remain fragmented and often separate from the main business.
In this white paper, IQVIA’s Data Science experts explore the reasons why AI/ML has had limited success in the biopharmaceutical industry to date, and contrast that examination with case studies spotlighting enterprises that successfully improved patient outcomes and streamlined internal operations through the use of AI/ML.
Download this white paper to discover how your biopharma organization can succeed in today’s increasingly complex and competitive environment by adopting AI/ML applications to enable:Decrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
